Kronos Bio, Inc. (KRON) Misses Q4 EPS by 17c
Tweet
Share
E-mailGet Alerts KRON Hot Sheet
Join SI Premium – FREE
Kronos Bio, Inc. (NASDAQ: KRON) reported Q4 EPS of ($0.43), $0.17 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.27 million versus the consensus estimate of $2.45 million.
For earnings history and earnings-related data on Kronos Bio, Inc. (KRON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Iridex Corp (IRIX) Misses Q2 EPS by 5c
- Freedom Broker Downgrades Flexsteel (FLXS) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
